J.A. Foekens

428 total citations
36 papers, 322 citations indexed

About

J.A. Foekens is a scholar working on Oncology, Molecular Biology and Genetics. According to data from OpenAlex, J.A. Foekens has authored 36 papers receiving a total of 322 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 11 papers in Molecular Biology and 10 papers in Genetics. Recurrent topics in J.A. Foekens's work include Estrogen and related hormone effects (6 papers), Neuroendocrine Tumor Research Advances (5 papers) and Cancer therapeutics and mechanisms (3 papers). J.A. Foekens is often cited by papers focused on Estrogen and related hormone effects (6 papers), Neuroendocrine Tumor Research Advances (5 papers) and Cancer therapeutics and mechanisms (3 papers). J.A. Foekens collaborates with scholars based in Netherlands, United States and Denmark. J.A. Foekens's co-authors include J.G.M. Klijn, J.G.M. Klijn, Henk Portengen, Jaco J. Verweij, T.C. Kok, A.S.T. Planting, Marinus A. Blankenstein, J.G.M. Klijn, M. Bontenbal and M.S. Henkelman and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Biochemical and Biophysical Research Communications.

In The Last Decade

J.A. Foekens

35 papers receiving 307 citations

Peers

Countries citing papers authored by J.A. Foekens

Since Specialization

Citations

This map shows the geographic impact of J.A. Foekens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.A. Foekens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.A. Foekens more than expected).

Fields of papers citing papers by J.A. Foekens

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J.A. Foekens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.A. Foekens. The network helps show where J.A. Foekens may publish in the future.

Co-authorship network of co-authors of J.A. Foekens

This figure shows the co-authorship network connecting the top 25 collaborators of J.A. Foekens. A scholar is included among the top collaborators of J.A. Foekens based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J.A. Foekens. J.A. Foekens is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Abstract P1-02-02: ESR1 mutations in circulating tumor cell versus circulating cell-free DNA of metastatic breast cancer patients before first-line endocrine therapy and at progression 2017 ·Cancer Research ·(unknown), Nick Beije, Jaco Kraan, Mai N. Van, Wendy Onstenk, (unknown), (unknown), Paul Hamberg, (unknown), (unknown), (unknown), Agnes Jager, (unknown), (unknown), J.A. Foekens, (unknown), Stefan Sleijfer	0
2	Abstract S4-07: Tamoxifen resistance driven by the DNA cytosine deaminase APOBEC3B in recurrent estrogen receptor positive breast cancer 2016 ·Cancer Research ·Reuben S. Harris, Emily K. Law, (unknown), Kelly LaPara, Brandon Leonard, (unknown), (unknown), Fred C.G.J. Sweep, Paul N. Span, J.A. Foekens, (unknown), Douglas Yee	1
3	Abstract P3-06-32: Topoisomerase 1 gene copy aberration is a frequent finding in clinical breast cancer samples 2012 ·Cancer Research ·Jan Stenvang, Marcel Smid, Søren Drud-Heydary Nielsen, Eva Balslev, Mieke Timmermans, Maria Unni Rømer, (unknown), I. J. Christensen, Dorte Nielsen, J.A. Foekens, N. Brünner, (unknown)	2
4	The use of genomic tools for the molecular understanding of breast cancer and to guide personalized medicine 2008 ·Drug Discovery Today ·J.A. Foekens, Yongyu Wang, Johan A. Martens, E. Berns, J.G.M. Klijn	13
5	Which cyclin E prevails as prognostic marker for breast cancer? Results from a retrospective study involving 635 lymph node negative breast cancer patients 2006 ·European Journal of Cancer Supplements ·Anieta M. Sieuwerts, Maxime P. Look, Marion E. Meijer‐van Gelder, Mieke Timmermans, Henk Portengen, J.G.M. Klijn, J.A. Foekens	4
6	Mammaglobin remains a useful marker for the detection of breast cancer cells in peripheral blood. 2005 ·Journal of Clinical Oncology ·Paul N. Span, Fred C.G.J. Sweep, L.V.A.M. Beex, J.A. Foekens	1
7	Feasibility, endocrine and anti-tumour effects of a triple endocrine therapy with tamoxifen, a somatostatin analogue and an antiprolactin in post-menopausal metastatic breast cancer: a randomized study with long-term follow-up 1998 ·British Journal of Cancer ·M. Bontenbal, J.A. Foekens, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), J.G.M. Klijn	37
8	Relationship of p53, uPA, pS2, EGF-R, and c-ERBB2, with response to systemic treatment in recurrent breast cancer patient 1997 ·European Journal of Cancer ·J.G.M. Klijn, (unknown), Maxime P. Look, Marion E. Meijer‐van Gelder, J.A. Foekens	1
9	Quantification of relative area of pS2 immunohistochemical staining and epithelial percentage in breast carcinomas: the effect of the latter on the interpretation of a cytosolic pS2 assay. 1995 ·PubMed ·(unknown), (unknown), (unknown), J.A. Foekens, (unknown), (unknown)	3
10	Prognostic value of cytosolic tyrosine kinase activity in 249 node-positive breast cancer patients 1994 ·British Journal of Cancer ·S Romain, Olivier Chinot, J.G.M. Klijn, WLJ van Putten, (unknown), (unknown), (unknown), J.A. Foekens	10
11	Response to adjuvant chemotherapy in primary breast cancer: no correlation with expression of glutathione S-transferases 1993 ·British Journal of Cancer ·(unknown), H.M.J. Roelofs, (unknown), J. B. M. J. Jansen, J.G.M. Klijn, J.A. Foekens	25
12	Somatostatin receptor‐positive primary breast tumors: Genetic, patient and tumor characteristics 1993 ·International Journal of Cancer ·Aart H. Bootsma, Steven W. J. Lamberts, Casper H.J. van Eijck, Kim Schouten, Annelies de Klein, J.C. Reubi, Beatrice Waser, J.A. Foekens, Renée van Pel, Ellen C. Zwarthoff	19
13	Direct Antitumor Effects of LH-RH Analogs 1992 ·Recent results in cancer research ·J.A. Foekens, J.G.M. Klijn	8
14	Manipulation of cell cycle kinetics: Influence on the cytotoxicity of doxorubicin in human breast cancer cells 1990 ·The Journal of Steroid Biochemistry and Molecular Biology ·M. Bontenbal, Anieta M. Sieuwerts, Harm Peters, Pieter Sonneveld, J.A. Foekens, J.G.M. Klijn	11
15	Treatment of patients with metastatic pancreatic and gastrointestinal tumours with the somatostatin analogue Sandostatin: a phase II study including endocrine effects 1990 ·British Journal of Cancer ·J.G.M. Klijn, (unknown), A.S.T. Planting, Jaco J. Verweij, T.C. Kok, (unknown), Henk Portengen, J.A. Foekens	73
16	Inhibin immunoreactivity in gonadal and non-gonadal tumors 1990 ·The Journal of Steroid Biochemistry and Molecular Biology ·Frank H. de Jong, A.J. Grootenhuis, Jacobie Steenbergen, F.J. van Sluijs, J.A. Foekens, F.J.W. ten Kate, J. Wolter Oosterhuis, Steven W. J. Lamberts, J.G.M. Klijn	28
17	Suramin: Pharmacokinetic monitoring, haematological and antitumor effects on rats bearing transplantable pancreatic tumors 1990 ·European Journal of Cancer and Clinical Oncology ·Buddy Setyono-Han, G.H. Bakker, Harry A. Peters, Anieta M. Sieuwerts, A.M.M. Eggermont, J.A. Foekens, J.G.M. Klijn	1
18	Modulation of development of dietary fat-promoted (pre)neoplastic pancreatic lesions in bop-treated hamsters by (anti) hormones 1990 ·European Journal of Cancer and Clinical Oncology ·(unknown), A. van Garderen‐Hoetmer, J.A. Foekens, G.H. Bakker, J.G.M. Klijn, R.A. Woutersen	1
19	Prophylactic neuropeptide-analog treatment of a transplantable pancreatic tumor in rats 1987 ·Journal of Steroid Biochemistry ·Buddy Setyono-Han, G.H. Bakker, Henk Portengen, J.A. Foekens, J.G.M. Klijn	5
20	Direct effects of LHRH analogs on tumor cells 1986 ·European Journal of Cancer and Clinical Oncology ·J.A. Foekens, M.S. Henkelman, (unknown), Marinus A. Blankenstein, J.G.M. Klijn	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact